Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China.
National Center for Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing Key Laboratory of Digital Stomatology, Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health, NMPA Key Laboratory for Dental Materials, National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, China.
Cancer Res Commun. 2024 Aug 1;4(8):2203-2214. doi: 10.1158/2767-9764.CRC-24-0169.
The role of mast cell (MC), a common myeloid-derived immune cell, in the development of oral squamous cell carcinoma (OSCC) is unclear. The aim of this study was to investigate MC infiltration in oral precancer and oral cancer. The evaluation of immune cell infiltration and its association with prognosis in OSCC used RNA sequencing and multiple public datasets. Multiplex immunofluorescence was used to explore the infiltration of MC in the microenvironment of OSCC and oral precancer and the interaction with CD8+ cells. The role of MC in OSCC progression was verified by in vivo experiments. The resting MC infiltration was mainly present in oral precancer, whereas activated MC infiltration was significantly higher in OSCC. Activated MC was associated with malignant transformation of oral precancer and poor prognosis of OSCC. In vivo studies showed that MC promoted the growth of OSCC. The infiltration of activated MC was negatively correlated with the infiltration of CD8+ T cells. The subtype of MC containing tryptase without chymase (MCT) was significantly higher in OSCC compared with oral precancer and was associated with poor survival. Furthermore, spatial distance analysis revealed a greater distance between MCT and CD8+ cells, which was also linked to poor prognosis in OSCC. Cox regression analysis showed that MCT could be a potential diagnostic and prognostic biomarker. This study provides new insights into the role of MC in the immune microenvironment of OSCC. It might enhance the immunotherapeutic efficacy of OSCC by developing targeted therapies against MC.
In this study, we investigated the role of mast cells (MC) in oral precancer and oral cancer and demonstrated that MCs are involved in oral cancer progression and may serve as a potential diagnostic and prognostic marker. It might improve the immunotherapeutic efficacy through developing targeted therapies against MCs.
肥大细胞(MC)是一种常见的髓系来源的免疫细胞,其在口腔鳞状细胞癌(OSCC)发生发展中的作用尚不清楚。本研究旨在探讨 MC 浸润在口腔癌前病变和口腔癌中的作用。使用 RNA 测序和多个公共数据集评估 OSCC 中免疫细胞浸润及其与预后的关系。采用多重免疫荧光法探讨 MC 在 OSCC 和口腔癌前病变微环境中的浸润及其与 CD8+细胞的相互作用。通过体内实验验证 MC 在 OSCC 进展中的作用。静止 MC 的浸润主要存在于口腔癌前病变中,而激活的 MC 浸润在 OSCC 中显著升高。激活的 MC 与口腔癌前病变的恶性转化和 OSCC 的不良预后相关。体内研究表明 MC 促进了 OSCC 的生长。激活的 MC 浸润与 CD8+T 细胞浸润呈负相关。与口腔癌前病变相比,含有类胰蛋白酶而非糜蛋白酶的 MC 亚型(MCT)在 OSCC 中明显升高,与生存不良相关。此外,空间距离分析显示 MCT 与 CD8+细胞之间的距离更大,这也与 OSCC 的不良预后相关。Cox 回归分析表明,MCT 可能是一种潜在的诊断和预后生物标志物。本研究为 MC 在 OSCC 免疫微环境中的作用提供了新的见解。通过开发针对 MC 的靶向治疗方法,可能增强 OSCC 的免疫治疗效果。
在这项研究中,我们研究了肥大细胞(MC)在口腔癌前病变和口腔癌中的作用,表明 MC 参与口腔癌的进展,并可能作为潜在的诊断和预后标志物。通过开发针对 MC 的靶向治疗方法,可能改善免疫治疗效果。